Articles On Avita Medical (ASX:AVH)

ASX health stocks rise 0.9% in past five days as broader markets lift 1.2%, despite Friday selloff ImpediMed’s latest quarterly result shows sales momentum building for Sozo device  Cold-cathode X-ray machine developer MicroX makes progres...

The ASX200 hit a fresh record high and closed up around 0.3% at 8,115 points, as the 2024 Wall Street rally continues to buoy Australian sentiment. Almost all sectors were up, led by Real Estate up 1.7%, followed closely by Information T...

ASX healthcare shares have outperformed in the past 12 months. The broad index, represented by the S&P/ASX 200 Index (ASX: XJO), is up 10.5% in that time. Meanwhile, the S&P/ASX 200 Health Care Index (ASX: XHJ), a proxy for the l...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Avita (ASX:AVH) has announced its development of a ‘dermal matrix’ – in other words, a kind of next-gen gauze made of a material closer to skin than cotton. The product’s development is being collaborated on with another entity called Re...

The ASX s expected to rise after the Fed suggested a possible rate cut in September Nasdaq soared by 2.64pc, with Nvidia surging by 12pc Gold and oil prices also surged due to geopolitical tensions   The ASX200 index is expected to climb...

The ASX is set to rise a fifth of a percent on Thursday according to futures around 8.30am Sydney time. Overnight, the US Federal Reserve made its latest interest rate decision; keeping rates on hold but signalling a September cut is sti...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Australian investors have shown an interest in ASX small-cap shares in recent weeks amid a sharp correction in the broader markets. As we entered the new financial year, the S&P/ASX Small Ordinaries Index (ASX: XSO) rallied 4.6% to...

Small cap ASX shares can be great additions to a balanced investment portfolio. This is because they tend to offer stronger than average returns. However, as they are higher risk options, they are generally unsuitable for investors with a l...

  Special Report: Dropping milestone numbers this week is the Perth-based regenerative medtech Orthocell, for which record quarterly and full year revenue has been driven by a huge uptick in demand across the company’s flagship healing solu...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

For biotech investors, the news of an approval by the US FDA is a genuinely exciting milestone. The FDA is the ultimate gatekeeper for the US pharmaceutical market, which is by far the world’s largest. Approval from the FDA not only validat...

If you have a high tolerance for risk, then it could be worth adding some exposure to small caps to your investment portfolio. Especially when analysts are tipping the three in this article to deliver outsized returns for investors over the...

For investors that have a high risk tolerance, it could be worth considering some small cap ASX shares for your portfolio. That's because the returns on offer at the small side of the market can be material. But which small caps could offe...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced that the US FDA has approved its premarket approval supplement for the RECELL GO System.

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Are you looking for big returns for your investment portfolio? If you are, then take a look at the three ASX shares listed below that have been tipped to rise materially by analysts. Here's what you need to know about them: AVITA Medical I...

ASX health stocks fall in past five days in line with broader markets as investors spooked by hotter than expected inflation Dimerix up 33% for week after inking second exclusive license deal for commercialisation of its Phase 3 kidney dis...

The ASX200 is trading up around 0.55% With strong performances from major medical companies, the healthcare sector is leading gains, up 1.2%, Discretionary follows, up nearly a per cent. IT is the only sector to fall into the red, dow...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At the time of writing, the benchmark index is up 0.55% to 7,670 points. Four ASX shares that are rising more than most today are li...

The All Ordinaries Index (ASX: XAO) is up 0.5% in morning trade with one ASX healthcare share doing plenty of the heavy lifting. Shares in the regenerative medicine company, which is focused on devices for wound care management and skin...

FDA approves AVITA’s RECELL GO System Wound care medical company, AVITA Medical ASX:AVH), surged +13% this morning after receiving an FDA approval for its latest product, the RECELL GO System. The RECELL GO system basically harvests a small...

31 May 2024 - A snapshot of the stocks on the move, featuring Telix Pharmaceuticals (ASX:TLX), AVITA Medical (ASX:AVH) and EZZ Life Science (ASX:EZZ).

Wound care management specialist AVITA Medical (ASX: AVH) has obtained US Food and Drug Administration (FDA) approval for its RECELL GO skin restoration system. RECELL GO is a cell-harvesting device that utilises the regenerative properties...

  To register for today's webinar click here. Telix Pharmaceuticals (ASX:TLX) announces additional positive data from the ProstACT SELECT trial of TLX591. TLX591 is an investigational anti-PSMA1 radio-antibody-drug conjugate (rADC) therapy...

Avita Medical (ASX:AVH) has announced the US FDA has issued a premarket approval for its RECELL GO skin cell harvesting device. The system allows patients requiring burns and wound treatment to see improved healing outcomes with less don...

ASX 200 expected to rise by +0.7pc at Friday’s market opening Tech stocks dragged Wall Street lower Donald Trump found guilty on all counts   The ASX 200 is poised to bounce back when the market opens on Friday. At 8am AEST, the ASX200 fu...

If you have a high risk tolerance, then it could be worth adding some small cap ASX shares to your portfolio. But which small caps could offer a compelling risk/reward? Listed below are two small caps that analysts are very bullish on right...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

ASX healthcare shares are one of only two market sectors trading in the green at the time of writing. The S&P/ASX 200 Health Care Index (ASX: XHJ) is up 0.55% and is the best sector of the day so far. These two ASX healthcare sha...

The market may be trading close to its record high, but the same cannot be said for the ASX shares in this article. Much to the dismay of their shareholders, these shares have just hit 52-week lows or worse. Here's what you need to know: A...

If you have a higher-than-average tolerance for risk, then you might want to consider adding some small caps to your investment portfolio. But which small cap ASX shares should you buy? Listed below are three that Morgans has on its best i...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

S&P/ASX 200 fell 2.94% in April as all Australian equity indexes fell except Emerging Companies Utilities and Materials the only ASX sectors in positive territory for April, up 4.77% and 0.61% respectively Rincon Resources  tops the wi...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

The Cettire Ltd (ASX: CTT) share price is out of fashion today as a sudden investor exit comes to light. Shares in the luxury fashion retailer are down 5.5% to $2.92 apiece around midday. The deepened retreat means Cettire shares are no...

The niggling threat of an inflationary acceleration is rearing its ugly head once again, setting ASX All Ord shares on track for their worst month since August last year. Nervousness has re-entered the chat this month. Increasing conflic...

While the journey from $1,000 to $10,000 may seem formidable, focusing on high-potential ASX growth shares could be the key. In this article, we'll explore three ASX growth stocks that I think have the potential to multiply an initial s...

The recent woes of Star Entertainment Group Ltd (ASX: SGR) shares have been a well-publicised debacle over the past few weeks and months. Earlier this week, we chronicled how the Star share price hit a new all-time record low of 47.8 cents...

The NextDc Ltd (ASX: NXT) share price is in the green today. Shares in the S&P/ASX 200 Index (ASX: XJO) tech stock closed flat yesterday at $15.55 a share. In morning trade on Thursday, shares are swapping hands for $15.70 apiece, up...

Many of Australia's top brokers have been busy adjusting their financial models again. This has led to the release of a number of broker notes this week. Three ASX shares that brokers have named as buys this week are listed below. Here's wh...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.091% to 7,605.60. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spot...

World Overnight SPI Overnight 7612.00 – 23.00 – 0.30% S&P ASX 200 7612.50 – 140.00 – 1.81% S&P500 5051.41 – 10.41 – 0.21% Nasdaq Comp 15865.25 – 19.77 – 0.12% DJIA 37798.97 + 63.86 0.17% S&P500 VIX 18.40 – 0.83 – 4...

Domino's Pizza Enterprises Ltd (ASX: DMP) shares closed down 3.11% yesterday trading for $37.38 apiece. This marked a new and unwanted multi-year low. The S&P/ASX 200 Index (ASX: XJO) fast food pizza retailer has been under selling pre...

They say time heals all wounds, but the situation has only worsened for Star Entertainment Group Ltd (ASX: SGR) shares over the past four trading sessions. In afternoon trading, shares in the casino operator are 12.99% lower at 42 cents...

The S&P/ASX 200 Index (ASX: XJO) is having a day to forget on Tuesday. In afternoon trade, the benchmark index is down a very disappointing 2.1% to 7,586.6 points. Four ASX shares that are avoiding the market selloff today are listed be...

The Zip Co Ltd (ASX: ZIP) share price is on the move on Tuesday. In morning trade, the buy now pay later (BNPL) provider's shares are up 3.5% to $1.39. Why is the Zip share price rising? Investors have been buying the company's shares this...

World Overnight SPI Overnight 7725.00 – 63.00 – 0.81% S&P ASX 200 7752.50 – 35.60 – 0.46% S&P500 5061.82 – 61.59 – 1.20% Nasdaq Comp 15885.02 – 290.08 – 1.79% DJIA 37735.11 – 248.13 – 0.65% S&P500 VIX 19.23 + 1.92...

Sure, it hasn't been a great start to the trading week for the Australian share markets so far today. At the time of writing, the ASX 200 has lost 0.48% of its value and is down to around 7,750 points. But let's talk about what's going on w...